Healthcare provider profile · identity verified

Steven Nelson Pyke, M.D.

Family Practice · NOVATO, CA · NPI 1366493116

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	517	172
Lisinopril	Lisinopril	380	129
Losartan Potassium	Losartan Potassium	337	116
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	315	51
Levothyroxine Sodium	Levothyroxine Sodium	279	90
Amlodipine Besylate	Amlodipine Besylate	242	86
Omeprazole	Omeprazole	190	58
Fluticasone Propionate	Fluticasone Propionate	187	66
Hydrochlorothiazide	Hydrochlorothiazide	180	61
Simvastatin	Simvastatin	176	53
Metoprolol Tartrate	Metoprolol Tartrate	166	43
Tramadol Hcl	Tramadol Hcl	165	34
Pantoprazole Sodium	Pantoprazole Sodium	153	51
Trazodone Hcl	Trazodone Hcl	153	49
Tamsulosin Hcl	Tamsulosin Hcl	146	48
Meloxicam	Meloxicam	144	42
Gabapentin	Gabapentin	139	41
Albuterol Sulfate Hfa	Albuterol Sulfate	132	66
Terazosin Hcl	Terazosin Hcl	129	39
Azelastine Hcl	Azelastine Hcl	113	49
Lorazepam	Lorazepam	112	31
Furosemide	Furosemide	106	37
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	106	42
Alendronate Sodium	Alendronate Sodium	104	33
Metformin Hcl Er	Metformin Hcl	102	41
Acyclovir	Acyclovir	101	32
Atenolol	Atenolol	99	32
Ibuprofen	Ibuprofen	94	30
Metoprolol Succinate	Metoprolol Succinate	75	27
Famotidine	Famotidine	74	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	74	30
Metformin Hcl	Metformin Hcl	74	24
Rosuvastatin Calcium	Rosuvastatin Calcium	74	28
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	72	12
Allopurinol	Allopurinol	66	22
Pradaxa	Dabigatran Etexilate Mesylate	64	18
Wixela Inhub	Fluticasone Propion/Salmeterol	63	16
Zolpidem Tartrate	Zolpidem Tartrate	60	12
Escitalopram Oxalate	Escitalopram Oxalate	59	24
Tizanidine Hcl	Tizanidine Hcl	58	16
Alprazolam	Alprazolam	57	19
Chlorthalidone	Chlorthalidone	57	23
Triamcinolone Acetonide	Triamcinolone Acetonide	56	36
Prednisone	Prednisone	54	25
Citalopram Hbr	Citalopram Hydrobromide	53	16
Spironolactone	Spironolactone	52	16
Alvesco	Ciclesonide	48	18
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	46	46
Duloxetine Hcl	Duloxetine Hcl	46	12
Clopidogrel	Clopidogrel Bisulfate	42	13
Colchicine	Colchicine	41	16
Hydrocortisone	Hydrocortisone	38	17
Finasteride	Finasteride	35	12
Fluocinonide	Fluocinonide	35	13
Montelukast Sodium	Montelukast Sodium	35	12
Potassium Chloride	Potassium Chloride	35	11
Acetaminophen-Codeine	Acetaminophen With Codeine	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	13
Pravastatin Sodium	Pravastatin Sodium	34	12
Naproxen	Naproxen	33	11
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Donepezil Hcl	Donepezil Hcl	32	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Morphine Sulfate Er	Morphine Sulfate	31	suppressed
Sertraline Hcl	Sertraline Hcl	31	14
Baclofen	Baclofen	30	suppressed
Diazepam	Diazepam	30	suppressed
Ondansetron Odt	Ondansetron	30	suppressed
Breyna	Budesonide/Formoterol Fumarate	29	11
Ipratropium Bromide	Ipratropium Bromide	29	suppressed
Lovastatin	Lovastatin	29	suppressed
Ozempic	Semaglutide	29	suppressed
Cephalexin	Cephalexin	28	18
Nortriptyline Hcl	Nortriptyline Hcl	28	suppressed
Celecoxib	Celecoxib	27	suppressed
Glipizide	Glipizide	27	suppressed
Jardiance	Empagliflozin	27	suppressed
Latanoprost	Latanoprost	27	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Clobetasol Propionate	Clobetasol Propionate	26	12
Estradiol	Estradiol	26	11
Bisoprolol Fumarate	Bisoprolol Fumarate	25	suppressed
Ketoconazole	Ketoconazole	24	suppressed
Metronidazole	Metronidazole	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Carvedilol	Carvedilol	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Oxycodone Hcl	Oxycodone Hcl	20	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	18	15
Tadalafil	Tadalafil	18	suppressed
Humulin N	Insulin Nph Human Isophane	17	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	16	15
Spiriva Respimat	Tiotropium Bromide	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	14	suppressed
Brilinta	Ticagrelor	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Veo Insulin Syringe	Syrge-Ndl,ins 0.3 Ml Half Mark	14	suppressed
Eliquis	Apixaban	13	suppressed
Nystatin	Nystatin	13	suppressed
Torsemide	Torsemide	13	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	12	suppressed
Dorzolamide-Timolol	Dorzolamide/Timolol/Pf	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Nabumetone	Nabumetone	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Oxazepam	Oxazepam	12	suppressed
Trospium Chloride	Trospium Chloride	12	suppressed
Digoxin	Digoxin	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Repatha Sureclick	Evolocumab	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Victoza 2-Pak	Liraglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error